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WHY DON’T ADOLESCENTS FINISH THE HPV VACCINE SERIES? A 
QUALITATIVE STUDY OF PARENTS AND PROVIDERS 
 
NAGASUDHA L. CHIGURUPATI 
ABSTRACT 
Purpose: To understand why adolescents who initiate the HPV vaccine series 
fail to complete all three shots. 
Methods:  Semi-structured interviews were performed with parents/guardians of 
11-17 year old daughters and pediatric primary care providers in one inner-city 
public clinic and three private practices to determine why girls who received at 
least one dose of the HPV vaccine did or did not complete the series.  The 
number of shots received was confirmed by electronic medical record review.  
Content analysis was used to identify themes related to series completion. 
Results: 65 parents/guardians participated: 37 whose daughters received 1 or 2 
doses of HPV vaccine and 28 whose daughters completed 3 doses.  Most (n=24, 
65%) parents/guardians failed to complete the series because they thought the 
clinics would remind them of subsequent doses. 9 (24%) cited logistical barriers. 
4 (11%) decided to stop the vaccine series. 33 providers participated: 24 
physicians, 3 nurse practitioners, and 6 registered nurses. 52% of providers told 
parents to schedule appointments, 41% scheduled the second dose at the time 
the first dose was given, and 7% tried to immunize patients when they returned 
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for other appointments; providers confirmed that few parents chose to stop the 
series. No practice had a system in place to ensure series completion. 
Conclusions:  Most failure to complete the HPV vaccine series occurred 
because providers expected parents to make appointments while parents 
expected to be reminded. Increased use of reminder/recall systems and clear 
communication of expectations regarding appointment scheduling could improve 
completion rates.  
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INTRODUCTION 
Basics of HPV 
Human papillomavirus virus (HPV) is the most common sexually transmitted 
infection.1 People who are infected with HPV can be asymptomatic, since 
symptoms can develop years following the initial infection and most times the 
immune system is capable of suppressing detectable vaginal infection within a 
two year time span.1–3 HPV consists of 150 viruses1, which can be divided into 
low risk and high risk viruses.4 These viruses have been associated with cancers 
of the vulva, vagina, penis, anus, and oropharynx.5 Low risk viruses like HPV6 
and HPV11 have been linked to genital warts and recurrent respiratory 
papillomas.4 High risk viruses like HPV16 and HPV18 are the source of most, if 
not all cervical cancers.6 The persistent association between HPV DNA and 
cervical cancer has been well documented.2,4–7 It has been noted that the link 
between HPV and cervical cancer is one of the strongest associations within 
human cancers.7 
 
Between the years of 2006 and 2010, there were 33,160 cancers diagnosed in 
the United States that were linked to HPV, of which females comprised of 20,589 
(62%) of these cases, and the remaining 12,571 (38%) belonged to males.8 Of 
these 33,160 cancers, 17,500 cases were linked to HPV16 and HPV 18.8 
Furthermore, around 31,351 woman of reproductive age passed away between 
the years of 1999-2010 due to some form of STD.  A leading 60% of STD-related 
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deaths were caused by HIV and the second major contributor was HPV causing 
34% of these deaths.9 
 
Prevalence of HPV 
It is estimated there will be 19.7 million new cases of sexually transmitted 
infections (STI) in the United States every year. Of these 19.7 million cases, 14.1 
million will be HPV diagnosis.2 Furthermore, nationally, it is estimated that when 
taking into account both new and existing STIs, there will be more people who 
are infected with HPV than any other STI, since a projected 79.1 million people 
have HPV of the 110 million who have STIs.2 
 
The occurrence of HPV was higher among those living below the poverty level, 
lower education level, younger ages, age of sexual debut, number of lifetime 
sexual partners, and marital status.10–12 One study reported that HPV had a 
prevalence of 56.5% in women who lived below the poverty level, whereas 
women who lived above the level had a HPV occurrence of 39.2%.11 There was 
31.4% incidence of HPV in women with a college education whereas women who 
possessed less than a high school education had a prevalence rate of 48%. 10 
Within the female age group 18-59 years, 41.9% of the women tested positive for 
some form of HPV.10  The risk of HPV infection was found to be higher with 
increasing age between the ages of 14 and 24, with the greatest prevalence of 
HPV in females between the ages of 20 and 24 years old with 44.8%.12 It is this 
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troubling trend that further supports the need to vaccinate girls in their younger 
adolescent years. When comparing girls who started having sex before their 16th 
birthday versus after, the occurrence of HPV increased by 89% in those females 
who were sexually active prior to them turning 16.10 Furthermore, women who 
had greater than 11 sexual partners in their lifetime are 8.9 times more likely to 
be infected with HPV as opposed to women who have had 0-1 partners in their 
lifetime.10 The incidence of HPV was also found to be associated with marital 
status, where women who were married had the lowest prevalence rate of 
29.4%, whereas as women who identified as single, divorced, or never married 
had an prevalence of greater than 47%.10 Race was also associated with HPV 
incidence rates. Non-Hispanic black females were 2.3 times more likely to have 
HPV when compared to non-Hispanic white females.10 Specifically, the highest 
HPV incidence rate of 59.2% belonged to the non-Hispanic black females. 
Mexican Americans had a prevalence of 44.2% and non-Hispanic whites had the 
lowest of the three groups with 39.2%.11 However, the rate of HPV infection 
among all women is high. 
 
HPV Vaccines 
There are currently two vaccines that are being administered for HPV. Cervarix 
(Bivalent HPV, HPV2) provides protection against HPV16 and 18 and 
subsequently helps to prevent cervical cancer. It was approved for use only in 
women between the ages of 9 and 25 years. It is a 3 dose intramuscular 
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vaccination that is administered at 0, 1 and 6 month interval. The most common 
side effects that were associated with Cervarix were swelling, pain and redness 
at the injection site. Fatigue, headache, and gastrointestinal symptoms were also 
noted.13 
 
Gardasil (Quadrivalent HPV, HPV4) is also a 3 dose vaccination that is 
administered at 0, 2 and 6 month interval. Unlike Cervarix, Gardasil can be 
administered in both males and females between the ages of 9 and 25 years. In 
both genders, Gardasil protects against HPV types 6, 11, 16, 18. In woman, it 
prevents cancers of the vulva, cervix, anus, vagina, and genital warts. In men, it 
protects against anal cancer and genital warts. Side effects that were noted 
included fever, headache, dizziness, nausea, and minor reactions including pain, 
swelling, and bruising at the injection site.14 
 
The Advisory Committee on Immunization recommends that girls are 
administered either the HPV2 or the HPV4 vaccination when they are 11 or 12 
years old. With both vaccines, the second dose should be administered 1 to 2 
months after the first dose, and the third and final dose should be given 6 month 
following the first dose. These vaccinations can also be administered to women 
between the ages of 13 to 26 years. If the female does not complete the 3 does 
by the time she is 27 years old, the second and third dose can still be given to 
her. Additionally, if the vaccination is interrupted after the first dose, the series 
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does need not be restarted, the second dose can be administered and the third 
dose can be given after at least 12 weeks. Moreover, the HPV vaccine can be 
administered with other adolescent-appropriate immunizations.8 
 
These vaccinations are further supported by the World Health Organization 
(WHO), who believe that this vaccine is of utmost priority in the battle to fight 
cervical cancer and other diseases associated with HPV.15 Moreover, getting 
vaccinated for HPV is a financially sound decision. It was calculated that when 12 
year old girls were vaccinated, the estimated cost per quality-adjusted life year 
(QALY) gained was between $3906 and $14,723.16 Moreover in 1999, there were 
1.6 deaths per 100,000 women related to HPV linked cancers, whereas in 2010, 
there were 1.3 deaths per 100,000, thereby reflecting a 19% decrease.9 
 
Struggles with Vaccine Acceptance 
Vaccinations are considered to be one of the biggest public health achievement 
of the twentieth century.17,18 Over the years, the safety and effectiveness of 
vaccines have only improved, but contrarily, there is a decrease in the public’s 
confidence in vaccines.18  There have been warnings that if there continues to be 
declines in vaccination rates, then there is an increased risk of infectious 
diseases, thereby leading to higher rates of morality.18,19 Recent outbreaks of 
immunization-preventable diseases are reminiscent of the disease outbreaks 
from the pre-vaccination era.19 With these increasing doubts and risks, it is 
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important that there needs to be a clear message conveyed to parents that not 
only addresses their concerns, but it also highlights the essential benefits of the 
vaccine.18  Over the decades, these vaccines that are currently viewed with 
skepticism helped to eradicate many of the infectious diseases. Many scientists 
believe that is the great success of these vaccines in eliminating these diseases 
is what is causing parents to be complacent about vaccinations.18,19  
 
When the Center for Disease Control and Prevention (CDC) stated that the 
vaccinations were the biggest public health achievement of the twentieth century, 
they also warned that the full efficacy of vaccinations can only be achieved if the 
following requirements are met: (1) parents need to understand that they must 
get their children immunized because these vaccinations help protect their 
children against potentially harmful infectious diseases, (2) providers need to be 
up to date on all modifications in the immunization recommendations, (3) vaccine 
supply should be readily available and properly funded, (4) scientists must 
continue their research into the vaccines while continuously testing their safety 
and efficacy, and (5) technology needs to be put in place to ensure that the 
vaccinations are administered to the public in a timely manner.17 
 
While battling the overall doubt in vaccinations, there is also troubling trend with 
vaccination rates in adolescents. Immunizations like the HPV vaccine need to be 
administered during the adolescent years.8 However in order for this occur, 
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teenagers need to visit their providers for some form of healthcare visit. It has 
been found that adolescents in their later years make three times fewer 
preventative care visits then younger adolescents.20 In females, these visits 
declined slowly after their 14th birthday, and continued to decline further ensuing 
their 17th birthday.20 Therefore, it is of utmost importance that the HPV vaccine 
be administered to the girls in their early adolescent years when they visit their 
provider at a higher frequency than they would in the subsequent years. 
 
Barriers to vaccination completion 
Currently available HPV vaccines21,22 prevent up to 98% of HPV 16/18-related 
cervical dysplasia, the precursor to cervical cancer, among unexposed patients, 
and the quadrivalent vaccine also prevents vaginal, vulvar and anal dysplasia as 
well as genital warts.21,22 Since the licensures of these vaccines, vaccine-type 
HPV prevalence has decreased by over 50%, and rates of cervical cancer 
precursors have declined.23,24 However, the overall rate of initiating and 
completing the HPV vaccine series among U.S. girls are only 54% and 33% 
respectively,25 and vaccination rates have stagnated from 2011 to 2013.8 The low 
rate of completion among those who start the series is of particular concern, as 
the long-term efficacy of incomplete vaccination is undetermined.26–28 Several 
studies found a lower rate of completion among girls of minority races as 
opposed to white girls.29–33 Moreover, girls of a lower socioeconomic status are 
less likely to complete the series when compared to those of higher 
socioeconomic classes.34,35 These are concerning correlations because poor and 
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minority women are at the highest risk for cervical cancer.36–38 Reasons for 
incomplete vaccination are not well understood.39,40 Therefore we conducted in-
depth interviews with parents/guardians whose daughters did and did not 
complete the HPV vaccine series and with pediatric providers to better 
understand barriers and facilitators of series completion. 
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METHODS  
 
Setting: This study represents a subset of interviews previously analyzed to 
examine HPV vaccine series initiation.41 The study took place in 2012-2013 at 
one inner-city public clinic serving low-income and minority patients and 3 sites 
(2 suburban, 1 urban) serving primarily white and affluent patients between 
September 2012 and July 2013.  The inner-city public clinic cares for a diverse 
adolescent population including 48% Black, 26% Latino, 20% White and 6% 
other races.  The private practice populations included 72% White, 12% Black, 
5% Latino and 11% adolescents of other races.  Eighty-four percent of patients at 
private practices had private insurance, compared with 25% at the inner-city 
public clinic. 
Participants: Parents/guardians with daughters between the ages of 11-17 years 
were eligible to participate in this study. These subjects were recruited when they 
accompanied their daughters to the clinic for preventative care or other problem-
related visits. Trained research assistants reviewed practice schedules to 
determine eligible patients and recruited parents in the waiting areas either 
before or after scheduled visits.  Because Black and Latino girls are less likely to 
complete the vaccine series, we intentionally oversampled parents/guardians 
who self-identified as Black and Latino. The subjects who identified themselves 
as African-American, Afro-Caribbean, Haitian, and African were classified as 
Black. The parent/guardian interviews were conducted in English, Haitian-Creole 
or Spanish. All the interviews were audio-recorded and then transcribed 
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verbatim.  Native speakers transcribed the Haitian-Creole and Spanish interviews 
which were then translated to English and then back translated to validate its 
accuracy.  Parents/guardians received a $20 gift card for participation. We 
recruited physicians, nurse practitioners, and registered nurses who provided 
primary care including HPV vaccination at the inner-city public clinic and private 
practices. At each interview site, a physician involved in the study recruited 
additional participants. The physicians were not compensated. The Institutional 
Review Boards of Boston University Medical Campus and Harvard Vanguard 
Medical Associates approved this study. 
 
Interviews aimed to determine reasons why girls who started the HPV vaccine 
series did or did not complete all three shots from the point of view of both 
parents/guardians and providers. Parent/guardian interviews elicited 
demographic information, vaccination status, perceptions related to parent-
provider communication, and reasons for completing or failing to complete the 
HPV vaccine series.  Provider interviews elicited practices that facilitated or 
hindered series completion. All interviews were coded by three to six 
researchers, and discrepancies were discussed to achieve consensus.  
Consistent with the methods of qualitative analysis, we used the data to generate 
codes that were revised following every coding meeting and accordingly 
recurring themes were identified.  When multiple reasons for series non-
completion were mentioned, transcripts were reviewed again by two researchers 
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to determine the primary reasons for failure to complete the series. 
Parent/guardian answers were compared across race/ethnicity, socioeconomic 
status, and practice settings (inner-city public clinic or private practice), to 
determine differences in primary reasons for completing or not completing 
vaccination.  Provider responses were assessed to determine common themes 
that facilitated or hindered completion. 
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RESULTS 
 
 Parents/guardians motivations for vaccination 
65 parents/guardians participated: 37 whose daughters received 1 or 2 doses of 
the HPV vaccine (Incomplete group) and 28 whose daughters completed 3 doses 
(Complete group) (Table 1).  Parents were asked about their motivations to 
vaccinate and the reasons behind why they did or did not complete the series.  
Parents/guardians in both the Complete and Incomplete groups shared similar 
motivations for vaccinating their daughters (Figure 1; Table 2; Table 5). When 
asked why it was important that their daughter get this vaccine, 71% (n=20) of 
the parents in the Complete group and 70% (n=26) of those in the Incomplete 
group stated they felt that the benefits of HPV vaccination outweighed the risks: 
“I think if they can be protected from any diseases and the risks are low, then it 
outweighs the risks of not doing it, then I think they should do it. It’s a good 
thing.” (44 year old mother of 15 year old, private clinic, Complete group). 
Another strong motivator, mentioned by 43% (n=12) of parents in the Complete 
group and 38% (n=14) of parents in the Incomplete group was the belief that 
parents were responsible for protecting their children with HPV vaccination: “If 
anything we can do for our children—if we can do anything, we should try to 
protect them health-wise, to give them some type of future. That’s why I do think 
it’s important” (50 year old mother of 14 year old, private clinic, Complete group).  
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Approximately one third of parents in both groups (32% n=9 in the Complete 
group; 27% n=10 in the Incomplete group) stated that their trusting relationships 
with their providers were their primary reasons for vaccinating. A smaller 
percentage of parents in both groups (n=3, 11% in Complete group and n=5, 
14% in Incomplete group) felt their daughters needed the vaccine because all 
adolescents are likely to have sexual intercourse at some point.  Thirteen 
parents/guardians (46%) in the Complete group vaccinated specifically to prevent 
cervical cancer, while only 16% (n=6) of parents/guardians in the Incomplete 
group cited this reason. Television commercials were mentioned as a motivating 
factor by three (8%) participants in the Incomplete group but none in the 
Complete group.  
 
Parents/guardians reasons for not completing the HPV vaccine series 
Eighty-nine percent of participants’ whose daughters did not complete the series 
had intended to complete it. Participants’ reasons for not completing the vaccine 
series fell into three broad categories: expectation that their provider’s office 
would remind them of future shots (expect reminder), inconvenience or access 
barriers (inconvenience), and changing their minds after the first shot (conscious 
decision) (Figure 2a Table 3, Table 4).  
 
Expect reminder: Most girls (65%, n=24) did not obtain all three shots because 
the parents/guardians expected that the clinic would contact them regarding any 
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additional doses.  Specific difficulties included in this category included: a lack of 
clinic reminders (n=5, 21%), subsequent appointments not being scheduled at 
the time of visit (n=5, 21%), and other missed opportunities, where the 
adolescent had an appointment but was not vaccinated (n=4, 17%), or where a 
parent/guardian forgot or missed an appointment and the appointment was not 
rescheduled (n=3, 17%). These parents/guardians felt that ensuring vaccine 
series completion is the responsibility of the healthcare system, not the patient:  
“It’s a physician’s job to discuss these things with parents. And you know, if it’s 
not being done, then that’s on them” (33 year old mother of 14 year old, public 
clinic, Incomplete group). The reliance on the medical system was clearly 
described by this parent:  “It’s in the system. They have all the records. So if it is 
important they will give it to her” (54 year old mother of 14 year old, public clinic, 
Incomplete group). Another parent added: “if they really are supposed to be 
given in six months, I would have hoped that they would call” (48 year old mother 
of 18 year old, private clinic, Incomplete group).  Lack of knowledge also played 
a role.  Most (57%) participants whose daughters did not complete the series 
were aware that three doses were needed, but only 11% accurately recalled the 
recommended dosing schedule.  Seven participants (29%) incorrectly thought 
that they had already completed the vaccine.   
 
Inconvenience: Nine parent/guardians (24%) mentioned access barriers or 
inconvenience as the primary reason for failing to complete the vaccine series 
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(Figure 2a, Table 3, Table 4).  Barriers included in this category included 
parents/guardians’ and adolescents busy schedules (n=5, 56%), other health 
problems that took precedence over completing HPV vaccine series (n=3, 33%), 
and long commutes to the clinic (n=1, 11%).   These parents were asked whether 
they would accept alternative sites such as a pharmacy or school for delivery of 
the second and third vaccine dose.  Sixty-three percent would allow their child’s 
school nurse to administer the second or third doses, and 22% would feel 
comfortable with other community sites like pharmacies, boys and girls clubs, or 
churches. 
 
Conscious decision: Conscious decisions to halt the series were reported by four 
participants (11%).  Interestingly, no parent/guardian stopped the series due to a 
side effect or adverse event.  One of the parents, who started the series was 
highly motivated to vaccinate: “Because I know that there’ll be some point in time 
she’ll be sexually active, so I’d rather [be] on board with it early to prevent what 
could or couldn’t happen. That’s why I choose to do it early.” This parent is an 
immigrant single mother who completed high school in her country of origin. Her 
daughter is on public insurance and sees her physician at a public clinic. 
However, this 34 year old Black mother had a negative experience with the 
person who administered the first shot to her 15 year old daughter. After this first 
dosage, the mother stated: “We just never went back to get it and I personally 
didn’t like the person that was giving the shot. I don’t think they know what they 
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was doing that particular time.” When asked if it would have made a difference if 
a different person had given the shot, she replied “Yea it would definitely make a 
difference. Definitely.”  
 
Another mother, stopped the vaccine series after the first shot due to negative 
media. This 35 year old, married, U.S-born, high school graduate with public 
insurance did not accompany her 16 year old daughter to her appointment where 
the daughter got the first shot of the HPV vaccine series; the physician spoke to 
the mother over the phone. When asked why she stopped the series, this mother 
stated, “I think I started hearing stuff, so I stopped.” When pressed for details on 
what exactly she heard, the mother was vague: “I don’t remember what I started 
hearing, but it was just… you know all the talk, I don’t know.” However, she later 
said she would support the HPV vaccine after receiving more education and 
when she perceived it as one of the “normal shots.” 
 
Another parent, decided to halt the vaccine series after her 16 year old daughter 
was given the first dose. She is a 52 year old Hispanic immigrant, college-
educated mother with public insurance and sees her daughter’s physician at a 
public clinic.  One of her other children had a rash following chicken pox 
vaccination, and she therefore had concerns about the side effects of the HPV 
vaccine: “All I know you know is that they are putting a virus in her body, and to 
me a virus is not good. We are trying to keep the virus out of her body so I don’t 
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understand why they would put a virus in her body to combat a virus that’s gonna 
come later on.” Initially the mother decided to vaccinate her daughter “because 
the doctor said she needed it, but I had doubts at the time.”  
 
The last of the four parents who decided to stop the series, did so because both 
the parents felt that vaccination was only needed after sexual debut. Their 
daughter got the first dose of the HPV vaccine when she was 11 or 12 years old. 
The father accompanied his daughter to this appointment, and he approved of 
the vaccine even though he did not have much information on it. When the clinic 
called home to remind the parents about the second shot, the mother found out 
about the HPV vaccine. After talking to her husband, both parents decided to 
postpone vaccination. Although the pediatrician has recommended the vaccine 
annually, the parents felt: “She is 17 she is very, I wouldn’t say immature, but she 
does not have a boyfriend and uh, that’s my- that’s where I’m coming from with it. 
And that she is not sexually active, there is no need to have the HPV shots.” 
Further along in the interview, the mother struggles with whether this vaccine is 
promoting sexuality in girls, “when parents hear ‘I’m giving my 11 year old 
daughter vaccines for sexually transmitted disease’’ it’s just like, you know, with 
the mentality before you know, giving contraceptives to children, does it give 
them permission?” 
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Providers’ impressions of reasons that patients do not complete the HPV 
vaccine series 
33 providers participated: 24 physicians, 3 nurse practitioners, and 6 nurses.  
Among the physicians and nurse practitioners that prescribe HPV vaccination for 
patients (n=27), their series completion plans included telling parents to schedule 
appointments (52%), scheduling the second dose when the first dose was given 
(41%), and trying to immunize patients when they returned for other 
appointments (7%) (Figure 2b).  Neither the inner-city public clinic nor the private 
practices had organized reminder systems at the time of the study.  In the 
absence of standardized systems, individual providers used different approaches 
even within the same practices.  
 
Expect parents to make appointment: Although most providers simply told 
parents to schedule subsequent appointments, many were concerned that this 
was not very effective: “We’re dependent on parents and families remembering 
to come and get a painful shot… I have virtually no belief that we’re very 
effective.”  Another provider at the inner-city public clinic described his typical 
experience with follow-up:  “We leave it to the parents, we tell them they have to 
come back in two months to get a second dose and they don't have to see the 
doctor… but we can't really make a nurse visit. So parents have to call typically 
to get that visit and a large number of kids don't get their second dose on 
schedule. So it's pretty frequent that I would see a kid a year later [for the second 
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dose].”   He also described the limitations in implementation of electronic medical 
records, “even though we've had an EMR for 12 years, we don't have an easy-to-
use reminder/recall system for patients.”  This sentiment was echoed in the 
private practices: “We have a lot that forget their second one and they come in 
for their checkup next year.”    
 
Scheduling second dose when the first dose is given:  Providers described more 
success when the second dose was scheduled at when the first dose was given: 
“I find that being proactive about it and saying, ‘We’re going to make you an 
appointment for you,’ or ‘We’re going to call you to make this appointment,’ tends 
to be more effective [than telling them verbally] for them actually completing the 
series in the time that it should be completed.” (Pediatrician, inner city clinic).  
Some even scheduled additional follow-up appointments for other medical 
problems at the time when the second shot was due.  Yet scheduling alone was 
imperfect: “So we schedule the second one at the time of the first. We don’t 
schedule the third one because… enough people don’t show up for the second 
one that then you’d have this bogus third appointment scheduled which couldn’t 
be done… and it does clog up the nurse’s schedule.”   Nurses at the private 
practices who did see patients for second dose appointments discussed 
difficulties scheduling the third appointment because their schedules only went 
out two months.   
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Catching up vaccination at other visits:  A minority of providers were unaware of 
any systems related to vaccine series completion: “We let the patients know, 
“You need to come back in two months for this vaccine you can book an 
appointment at the front desk.” From there…. I don't know if they go on a list and 
they get called or if it’s something that just gets dropped, I have no idea.”  These 
providers relied on giving patients the next vaccine when they returned for a 
subsequent visit, but realized that competing priorities made this challenging: 
“when you're not busy occasionally [you review the immunization record]… but 
I'd say in reality, most of us don't do that and we’re busy.”  Another provider 
added: “some of these HPV’s are on the one year plan. You know, they get 
number 2 a year later, number 3 a year later.” 
 
Similar to parents/guardians, providers also stated that most failures to complete 
were due to a lack of systems, not a conscious decision to stop the series: “I’ve 
had maybe a half a dozen that I can think of off the top of my head… that have 
had one HPV and the parents refuse to continue the series and they’ve had no 
adverse reaction to it, none.”  Another provider concurred: “I think I’ve only had 
like one patient ever [stop the series]... They just get busy. They forget. They 
don’t schedule it.”  Providers stated that completing the series was harder for 
older adolescents because they less often presented for care, and had more 
competing demands on their time: “The later teens, if for some reason they’ve 
pushed it off [are less likely to complete the series]. They’re just busier with 
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sports and school work and what not. Which is unfortunate because they are 
probably the ones who really need it to be done.”   Other providers commented 
on the difficulty with vaccinating older teens: “The big no show rate and then a lot 
of teenagers don’t think they need to come in because there are no real required 
shots after 11… and then they feel kind of invincible.”  Clinic systems that 
providers stated could facilitate vaccine series completion included standing 
orders for second and third doses, walk-in appointments, and reminder cards 
with the due dates of each subsequent dose.  Some practices had partially 
implemented some of these ideas. 
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Table 1. Demographic characteristics of parents/guardians 
Variable Complete  Incomplete P value* 
Total  28 37  
Age of parent/guardian 
   Mean (range) 
49.2 (32-65) 41.7 (27-54) <0.001 
Race n (%) 
   White 
   Black 
   Hispanic 
    Other 
 
19  (68) 
4    (14) 
4    (14) 
1    (4) 
 
5   (14) 
20 (54) 
6   (16) 
6   (16) 
 
 
<0.001 
Interviewee is 
   Mother 
   Father 
   Guardian 
 
23 (82) 
3   (11) 
2   (7) 
 
35 (95) 
1   (3) 
1   (3) 
 
 
0.34 
Interviewee is 
   Male 
   Female 
 
3   (11) 
25 (89) 
 
1   (3) 
36 (97) 
 
0.31 
Marital status 
   Married 
   Single 
Divorced/Widowed/Separated 
   Non-marriage partners 
 
18 (64) 
3   (11) 
6   (21) 
1   (4) 
 
14 (38) 
12 (32) 
8   (22) 
3   (8) 
 
 
0.11 
Country of origin 
   US 
   Other 
 
26 (93) 
2   (7) 
 
24 (65) 
13 (35) 
 
0.008 
Religious affiliation 
   No 
   Yes 
 
12 (43) 
16 (57) 
 
18 (49) 
19 (51) 
 
0.64 
Education 
   Less than high school 
   High school graduate 
   Some college 
   College graduate 
   Post-college 
 
2  (7) 
6  (21) 
7  (25) 
8  (29) 
5  (18) 
 
6   (16) 
15 (41) 
8   (22) 
6   (16) 
2   (5) 
 
 
0.009 
Household income 
  <$20000 
  $21-40000 
  $41-60000 
  $61-100000 
  >$100000 
 
4   (15) 
6   (22) 
4   (15) 
2   (7) 
11 (41) 
 
15 (42) 
7   (19) 
7   (19) 
4   (11) 
3   (8) 
 
 
<0.001 
Insurance 
  Public 
  Private 
 
12 (43) 
16 (57) 
 
25 (68) 
12 (32) 
 
0.046 
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Table 2. Motivating Reasons to Vaccinate 
 
Complete 
(n=28) 
Incomplete 
(n=37) 
n % n % 
Vaccine Benefits Outweighs Risks 20 71% 26 70% 
Cervical Cancer Prevention 13 46% 6 16% 
Parent Responsibility to protect children with 
vaccine 12 43% 14 38% 
Trusts Physician 9 32% 10 27% 
Teen Sexuality is inevitable 3 11% 5 14% 
Positive Media Influence 0 0% 3 8% 
 
 
 
 
 
Figure 1. Motivating Reasons to Vaccinate in the Complete & Incomplete 
Groups - In their interviews, parents in both the Complete and Incomplete 
groups stated various reasons as to why they were motivated to have their 
daughters complete the HPV vaccination series. A majority of these parents 
stated more than one motivating reason behind their decision to vaccinate their 
daughter, and each reason was factored in when computing these percentages. 
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Table 3. Categories of Barriers Faced by Parents in the Incomplete Group 
CATEGORY REASON n % 
Expect Clinic 
Reminder 
(n=24, 65%) 
Lack of knowledge/ Inaccurate knowledge 
of dose and/or schedule 
12 50% 
Failure to complete not intentional: Thought 
to complete or thought incorrectly that they 
completed 
7 29% 
No clinic reminders 5 21% 
Subsequent appointment not scheduled 5 21% 
Ensuring completion is physician's/clinic 
responsibility 
4 17% 
Missed Opportunities: Adolescent had 
another appointment but was not 
vaccinated 
4 17% 
Forgot/Missed Appointments 3 13% 
Inconvenience 
(n=9, 24%) 
 
Busy Schedule/Job 5 56% 
Other Underlying Health Conditions-
Vaccination not a priority 
3 33% 
Long Commute 1 11% 
Conscious 
Decision 
(n=4, 11%) 
Negative Experience with First shot 1 25% 
Misconceptions/Rumors 2 50% 
Intend to delay until they feel daughter is at 
risk for sexual activity 
1 25% 
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Figure 2a: Barriers Faced By Parents in the Incomplete Group- The parents 
in the incomplete group listed numerous barriers that they faced in their efforts to 
have their daughters complete the HPV vaccine. Each parent stated fell under 
one of the three main categories of barriers: Expect Clinic Reminder, 
Inconvenience, and Conscious Decision. 
 
 
Figure 2b: Provider’s Plans- The 27 providers who administered the HPV 
vaccination made their attempts to ensure that the adolescents complete the 
vaccine series. Their stated efforts fell into the three main categories: Expect 
Parents to Schedule Appointments, Schedule 2nd Dose at time of First 
Appointment, or Opportunistic. 
 
[VALUE] 
24% 
[VALUE] 
BARRIERS FACED BY PARENTS IN THE INCOMPLETE 
GROUP 
Expectation Mismatch
Inconvenience
Conscious Decision
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Table 4. Summary of Barriers 
Difficult to come back for all three shots/Forget 
“I think it’s just one of those things. You get busy and then you put it off 
and the next thing you know, you never went back to have a follow-up. 
I’m guilty of it so I can see that happening. It’s unfortunate that it can’t 
be done in one shot.” --Caucasian mother of 14 year-old, private 
practice, Complete Group 
 
“A lot of people are, you know, it’s not that they don’t want to do things, 
it’s just that we’re busy, we forget, don’t realize the importance” --
Caucasian mother of 15 year-old, private practice, Complete Group 
 
“I forgot that she had the second appointment. Typically normally she 
is a healthy child and she has always been up to date on 
immunizations and because she’s not sexually active it didn’t seem 
emergent to me for her to have it…have it like that.” –Black mother of 
11 year-old, public practice, Incomplete Group 
 
“I’m a procrastinator, and what can I do to improve it, uh I don’t know, 
but I am going to let her finish it. But I don’t know why people would 
start it and not finish it, other people. Maybe they had a bad 
experience with the first  one and they just scared to go back to the 
second one, or maybe they have scheduling problems , I don’t know” –
Black mother of 13 year-old, private practice, Incomplete Group 
 
“I almost missed the third one just because of the time frame but I 
think it probably that people forget or they don’t schedule that 
appointment right away and if you’re like me three months goes by in 
woop, and you miss the window”—Caucasian mother of 15 year old, 
private practice, Complete Group 
Lack of Reminders/ Clinic Responsibility 
“Because parents today they are very busy working, keeping the 
schedule, send the kids to school, keep the kids in school, it’s too 
much stress for parents today. Then you know to keep in track all of 
the appointments and everything, it’s very difficult so if the staff at least  
can remind them when they go to visit the doctor that what vaccine 
they missing so that way they keep a track of the kids vaccinations 
and that way they can help the kids to prevent this.”  --Hispanic mother 
of 17 year-old, private practice, Complete Group 
 
“I want to come, I want to be there. If it’s to be given, let them phone 
the parent to bring them. Because sometimes they don’t know. They 
cannot remember. They are busy with their lifestyle or whatever.” –
Black mother of 13 year-old, public practice, Incomplete Group 
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“I didn’t know it was three shots. Maybe if they don’t do it on the visits, 
they don’t call you back and say this is what happened then you know 
you don’t really know” -- Black mother of 12 year-old, public practice, 
Incomplete Group 
 
“I would have probably brought her if I had gotten something just to 
remind me” –Caucasian mother of 11 year-old, private practice, 
Incomplete Group 
 
“Like I said um we moved and changed doctors and um…cause I just 
wasn’t aware of how often she had to have a shot I never had it done 
again” –Hispanic mother of 14 year-old, public practice, Incomplete 
Group 
 
“I think it all really depends on the physician being on top of it. And if 
the physicians are not on top of it—that’s kind of what probably plays 
it. Because, like I said, I was told that they’re fine until February. So, 
you know what I mean? Like, if I don’t receive an appointment  and I 
try to make one and they don’t, like, really mention it, then—I’m 
making it, you know what I mean?... It’s a physician’s job to discuss 
these things with parents. And you know, if it’s not being done, then 
that’s on them.” –Caucasian mother of 14 year-old, public practice, 
Incomplete Group 
 
 “They should have scheduled it I guess, they should have told me to 
schedule it” – 40 year old mother of 14 year old, public clinic, 
incomplete Group 
 
Lack of Information 
“Talk  to them more about that vaccine, let them know what other, you 
know consequences, if you get your vaccine, what does it do to your 
body, what does it protect you from, and if you don’t get the vaccine, 
what else can happen if you can’t get it, I mean if you don’t get the 
vaccine. Give them the pros and cons”  —Hispanic mother of a 17 
year-old, public practice, Complete Group 
 
“I also think that there’s a lot of preconceived notions that vaccines in 
general are the cause of the rise in autism and you hear a lot of crazy 
theories out there as to people want to blame everything on vaccines” 
-- Caucasian mother of a 15 year-old, private practice, Complete 
Group 
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“You know like the parents are probably not fully educated, um they 
forget, they  don’t have all the correct information or know the 
importance of it to continue the whole series” –Hispanic mother of 14 
year-old, public practice, Incomplete Group 
 
“More information. Explain more. No one explained it to me, honestly 
and I’m really pissed about that.”  --Caucasian mother of 11 year-old , 
public practice, Incomplete Group 
 
Economic Reasons/Copays 
“You mean why they didn’t finish it? Could be a thousand reasons. 
Like me, I’m lucky I’m here today because I have no gas and I have no 
money and I couldn’t pay my  rent. You know, it’s a tough economy 
right now. Having co-payments are always an issue”--Caucasian 
mother of 16 year-old, private practice, Complete Group 
 
“My husband obtained employment, and we got our health insurance 
back. And then we got my daughter back to see her doctor again and 
we got caught up on everything…Hey, if it comes down to buying milk, 
bread and meat for my house, or, give—unfortunately—coming to give 
20 dollars for a shot, when I can feed my daughter, I’m gonna to feed 
my daughter. And postpone the shot until I’m able to come. I got the 
shot, she got them. She has them all. But I had to make the decision 
to delay it or to feed her” --Caucasian mother of 14 year-old, private 
practice, Complete Group 
 
 
 
Table 5. Summary of Motivators 
Vaccine Benefits Outweigh Risks 
“Because it’s a harmless vaccine that can be lifesaving.” –Black 
mother of 16 year old, public clinic, Complete Group 
 
“Because the side effects are minimal to non-existent. It’s not going 
to hurt her. It’s going to help her. And I don’t know what they are 
going to do in the future” –White father of 17 year old, private clinic, 
Complete Group 
 
But from what she was saying, it seems that there’s more good to it 
than bad. Period. So, I accepted that.” –Black mother of 17 year old, 
public clinic, Incomplete Group 
 
“As long as you look for a solution now to something that could be a 
problem for you in the future, it’s better for you. You can’t wait to give 
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a child a vaccine when they are all grown up.” –Black mother of 13 
year old, public clinic, Incomplete Group 
 
“They basically talked about preventing this disease from occurring. 
They also told me uh... she doesn’t have to take it but they have 
done more studies and it’s coming out that they could be at more of 
a risk later. So I said to myself, it’s been studied, it’s been here for a 
while. I see nothing bad come out of it. I did check with the CDC just 
to see if there is anything crazy out of it and it seemed fine. I said 
why not.” –35 year old father of 16 year old, public clinic, Incomplete 
Group 
 
Parent Responsibility to Protect Child with HPV Vaccine 
“I'd be more concerned not vaccinating her. If it was something she 
was exposed to and I could have protected her, I’d feel bad if she got 
something that I could have vaccinated her for” –White mother of 11 
year old, private clinic, Incomplete Group 
 
“I cannot be at home 7 days a week, and 24 hours a day watching 
them, behind them. So it is better for me to them to get protected 
then let them by themselves and then they get this type of thing” –
Hispanic mother of 17 year old, private clinic, Complete Group 
 
Trusts Physician 
“Basically we just, whatever our doctor recommends we go with it. I 
figure that he’s the person that you know is taking care of their 
healthcare and whatever and if he recommends something, he 
wouldn’t recommend something that isn’t good for them” –Black 
mother of 13 year old, public clinic, Incomplete Group 
 
“Whatever the doctor thinks. I put my faith in him” –White mother of 
16 year old, private clinic, Complete Group 
 
Teen Sexuality is Inevitable 
“I think it’s really important cause like I said, girls these days, they 
need all the vaccinations they can get, they are too sexually active 
out there and like I told you, you can still have the vaccine for the 
HPV but it still doesn’t protect you, you could still get warts or 
whatever the case may be” –Hispanic mother of 17 year old, public 
clinic, Complete Group 
 
“I mean I think that  vaccine exists for a reason and if there is a way 
to prevent sexually transmitted diseases its worth doing” –White 
mother of 15 year old, private clinic, Complete Group 
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Cervical Cancer Prevention 
“I’d never want wake up one day and she has cervical cancer. And I 
had the opportunity to prevent or slow it down or whatever” –Black 
father of 16 year old, public clinic, Incomplete Group 
 
“I want them to be protected. I mean I don’t want my girls to get 
cancer. I mean it does run in my family and if I could prevent it I’m 
going to do it as long as it doesn’t harm my girls, I mean I understand 
there are side effects from everything. Everything that we do, we eat, 
the shots so if that’s going to help them, prevent them from getting 
cancer, I’m going to do it. ” –White father of 15 year old, public clinic, 
Incomplete Group 
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DISCUSSION 
Most parent/guardians intended to complete the HPV vaccine series. However, 
65% of parents/guardians expected to be reminded of any needed doses, while 
52% of providers relied on parents to schedule subsequent shots, and no 
practice had a functional reminder or recall system for adolescent vaccinations.  
Because medical practices frequently reach out to patients with appointment 
reminders and other information, many parents/guardians were expecting to be 
reminded of the timing of subsequent doses.  Some of the parents believed in the 
efficacy of the vaccine, but because they had an inaccurate knowledge of the 
schedule and dosage of vaccine, they did not know when to schedule the shots. 
This expectation mismatch that led to a large percentage of the daughters not 
completing the series. Literature shows that a variety of reminder and recall 
systems can be effective for improving vaccination rates.   Interventions with 
proven efficacy include phone calls, educational brochures, letters, and text 
messages.42–47 Some states support centralized immunization information 
systems or registries also provide useful tools for reminder and recall systems, 
and have also been shown to increase vaccination rates.48  
 
A majority of the patients assumed that they would get reminders from the clinic, 
whereas the clinic expected the parents to remember their own appointments. 
This issue can easily be addressed. Practices and clinics can instill a reminder 
system where they can reach out to their patients to remind them of upcoming 
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vaccines that they might be due for. Resources like the Immunization Information 
Systems (IIS) can be utilized to support electronic individual patient records. IIS 
have been proven to increase the vaccination rates.48 These systems are 
effective in not only providing reminders to the patients, but are also helpful in 
keeping records of the patients’ vaccination status.48 Reminder and recall 
systems are another method that have been implemented in various ways to 
being about positive results.  One study found that the reminder or recall system 
is effective in 80% of the cases to help complete their vaccinations.42 Another 
study noted that when patients received a combination of a reminder phone call 
and an educational brochure, they were 22.5 times more likely to complete the 
HPV vaccine than those patients who did not receive the reminder and 
brochure.43  In addition to phone reminders, reminder letters were also found to 
be successful in increasing the completion rates of the HPV vaccine.44 Text 
messages have also been noted to be an effective intervention to increase HPV 
vaccine completion and immunization coverage in patients.45–47  Regardless of 
the type of reminder that is sent out to patients, multiple studies have found the 
effectiveness of a Reminder or Recall system intervention in increasing the 
completion rates of vaccinations. 
 
The second most common reason parents cited for not completing the series 
was inconvenience, specifically difficulty finding time in their busy schedules to 
make clinic appointments to complete the series.  Literature indicates that 
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adolescents older than age 14 have fewer medical visits than younger 
adolescents, with an especially strong age-related decline in preventive visits at 
which vaccines are often administered.20 Alternative sites for vaccine delivery, 
such as schools and pharmacies, could increase completion of the three dose 
series.  Two-thirds of parents/guardians interviewed would allow their children to 
complete the vaccine series in school.  Expanding the settings in which vaccines 
can be delivered may be a promising avenue to improve completion of 
adolescent vaccine series. 
 
Healthcare access is often cited as a reason for non-adherence to a variety of 
medical recommendations.  However, study participants did not cite access as 
barrier to completing the vaccine series, specifically denying financial costs of the 
vaccine, transportation to the clinic, and the ability to cancel and reschedule 
medical appointments.  This study took place in Massachusetts however, where 
universal healthcare has been in place since 2006, which may have overcome 
some access-related barriers. In states where access to primary care, including 
vaccination, is more limited, financial barriers may be more problematic.  Studies 
in other areas have found significant relationships between out-of-pocket vaccine 
costs and rates of HPV vaccination.49–52   
 
The cost of the HPV vaccine is a significant barrier to vaccination.49–52  
Adolescents may not have access to healthcare or if they have the healthcare, 
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they might not be using it.53 The costs of immunizations are increasing and it is 
challenging for the adolescents to find ways to finance their healthcare.53 
Females are more likely to be infected with HPV if they do not have health 
insurance, or a place to obtain health care.10 One study found that the most 
common reason why the HPV vaccine was refused was due to concerns about 
insurance coverage for this vaccine and those who had insurance coverage for 
the HPV vaccine had five times the odds of having had it.49 Furthermore, it has 
been noted that parents with higher incomes are willing to cover the cost of the 
HPV vaccine, whereas parents who have declined medical care due to either its 
cost or their health insurance status are less likely amenable to cover the costs of 
the vaccine.51  If the patient knew that the HPV vaccine was going to be covered, 
then this was the strongest predictor of vaccine acceptance.49   
 
Our study took place in an urban and city setting where the subjects had many 
transportation options, ranging from their personal cars to an extensive public 
transportation system.  However, transportation is a major barrier to health care 
access.54–60 In one study, 51% of the families stated that the chief reason for 
missing their appointment was connected to transportation problems.60 People 
with a driver’s license had 1.92 times more regular doctor appointments 
compared to those people who did not possess a license.56  The importance of a 
driver’s license and access to a car is highlighted when considering that in one 
study, 82% of the people who made it to their appointments had a car, whereas 
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in the patients who missed their appointments, only 58% of them had access to a 
car.59 In the absence of a car, people tend to rely on public transportation to 
travel to their appointments. However, the public transportation system also 
posed problems to people. In one study, people stated that the public bus system 
was unreliable, inefficient, and some reported that they had trouble affording the 
public transportation.58 Moreover, people faced higher rates of transportation 
barriers when they had a lower socioeconomic status when compared to those 
with a higher socioeconomic status.54 Furthermore, people in rural areas faced 
more barriers in that rural residents are 4 times more likely to travel 30 miles or 
more than their urban counterparts to access care.57 Due to the location of our 
study and the proximity to public transportation, our subjects report that 
transportation was not a barrier in their efforts to complete the HPV vaccination.  
Although our suburban practices were not near to public transportation, the 
parents attending this practice reported that transportation was not a barrier. 
 
Another common barrier to healthcare access is the flexibility of the patient’s 
schedule. As stated above, the subjects in this study did not face this hurdle. 
However, it has been reported that people have difficulty in getting time off of 
work. This trouble was more prevalent in parents with a lower socioeconomic 
status.55 Although there were working parents within this study, they stated that 
this barrier did not play a significant role. 
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Only four of the 37 parents interviewed who did not complete the series made the 
conscious decision to stop the vaccination series, and their beliefs were distinct: 
a negative experience with a staff person, misconceptions regarding vaccine side 
effects, and lack of understanding of the reasons for vaccinating in advance of 
sexual debut.  Of note, neither parents/guardians nor providers mentioned 
personal experiences with side effects as reasons why parents stopped the 
vaccine series. Many of the concerns voiced by parents could potentially be 
addressed by discussions with their providers. When providers treat questions 
and hesitation by parents as opportunities for education, vaccine hesitant parents 
are more likely to vaccinate.61–65  If hesitant parents are given the opportunity to 
voice their concerns and opinions, and the provider can address them 
systematically, the parents may be more likely to react positively.62   
 
One woman halted the vaccine series because of a negative experience that she 
had with the staff, but if she was informed by her physician that she can advocate 
for herself, then her daughter could have finished the vaccine series. Two 
parents halted the series because of the misconceptions or rumors they have 
had or heard concerning the vaccine. If the providers had taken the opportunity 
to probe the parents’ reasoning that’s fueling their doubts, then these 
misconceptions may have been amenable to education that could have been 
provided by the physicians. When providers are faced with misconceptions such 
as these, they should attempt to understand and analyze the sources of these 
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concerns and then address them accordingly.64  Furthermore, it has been 
previously shown that when a physician uses a participatory tone with the parent 
when discussing vaccinations, then the chances are greater that the vaccine 
hesitant parents will initiate the vaccine.62 When the provider uses a participatory 
tone, he is opening up room for discussion by asking the parents if they want 
their child to be vaccinated. This allows the parents to participate and have an 
equal role in the decision-making process. Through these discussions, they will 
have the opportunity to voice their concerns and opinions, which the provider can 
then address.62   
 
The last of the four parents halted the series because she deemed her daughter 
too young for the vaccination, yet despite her hesitance, the pediatrician is 
reminding the parents at every annual physical about the HPV vaccine and the 
benefits it can provide for their daughter.  This pediatrician’s pursuance of 
educating the parents is what is recommended by multiple studies.61–65 A strong 
and trusting relationship should be present between the physician and the 
parent. This trust will allow the parents to share their concerns and questions 
with the physicians.  Moreover, vaccine hesitant parents accredit their doctors 
when they change their mind and decide to vaccinate their children.61 Parents 
were 2 times more likely to believe the vaccines were safe for their kids if they 
reported that their physicians influenced their decisions to support 
immunizations.65  It has been noted in previous studies how important of a role a 
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physician plays in influencing a parents’ decision on vaccinating their children. 
Physicians should address the concerns of parents by using evidence-based 
data, but they should simplify the language so that it can be easily understood. 
This dissemination of knowledge by the providers will help the parents make an 
informed decision.64 A trusting relationship between a physician and a parent is 
vital especially when the parent refuses a vaccination. If the physician provides 
the proper education for their questions and is nonjudgmental when listening to 
the parent’s concerns, then the parent is more amenable to the idea of 
vaccinations.63 This pediatrician’s pursuance of the HPV vaccine at every 
physical is the perfect example of what providers should do when faced with 
parents who are hesitant about the HPV vaccine, because this pediatrician has 
had a positive impact on this mother because she wants her daughter to not only 
start the vaccine series but also to complete it.   
 
LIMITATIONS 
This analysis reports on a subset of previously described interviews.41 The 
limitations of this qualitative study include geographic constraints which may 
impact its breadth of applicability across the United States and the small and 
non-random sample size of subjects. Nevertheless, this study included urban and 
suburban families belonging to diverse cultural, linguistic, racial/ethnic, and 
socioeconomic backgrounds and a diverse array of providers who serve them. 
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CONCLUSION 
Most cases of non-completion are unintentional, usually resulting from parents 
expecting reminders from healthcare systems and providers expecting parents to 
schedule appointments. Therefore, reminder and recall systems have great 
potential to improve completion rates.  Inconvenience, the second most common 
reason for not completing the series, could be addressed by increasing 
alternative settings for vaccination, such as schools or pharmacies. 
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To broaden my experiences in the job world while improving my science education and 
my informatics skills 
To gain work experience relevant to my eventual goal of becoming a physician and a 
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Education 
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REGISTRATION COORDINATOR/BED CONTROL COORDINATOR | NEWTON-
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and a bed control coordinator 
 Check-in expectant mothers for a variety of appointments  
 Admit newborns upon their birth  
 Admit babies to the special care nursery 
 Process patients’ paperwork and update their files 
 Process the death paperwork for all fetal demises and all deaths on the maternity floor  
 Admit patients from the emergency room and other direct admissions 
 Responsible for interface with nursing supervisor and hospitalists. 
 Facilitate and act as a central contact for any issues with admissions into the hospital. 
 Depending on patient’s diagnosis, I had to place them on a suitable floor. With most 
patients, discussions with the hospitalist, nursing supervisor, and charge nurses on 
the units were needed to determine a patient’s placement.   Placement not only 
depends of the patient's current diagnosis, but on also his or her medical history, and 
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the staffing limitations on the floors. Upon confirming a room, I process the 
paperwork 
 Handle the death paperwork and verify its accuracy before releasing the body to their 
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 Aided patients with their problems as they await to be seen by the doctors and nurses  
 If the patient had visitors, I had to verify the patients' availability with the nurses. 
Depending on the nurse's response, I would either take the family to the patient or 
convey to them that they could not visit 
 Regardless of the difficulty of the situations, everything must be dealt with poise and 
respect 
VERNON CANCER CENTER VOLUNTEER | NEWTON-WELLESLEY 
HOSPITAL | JUNE 2010-AUGUST 2010 
 Guide visitors around the clinic, whether they were there for doctors’ appointments, or 
one of their numerous chemotherapy sessions 
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 Help treat participants with minor injuries 
 work alongside nurses and doctors to help treat world-class runners 
 Trained to take even the most stressful situations in stride and have been taught to 
handle all problems with composure and patience. 
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 Coordinating the marketing aspect of Camp Kangaroo, a children’s Bereavement 
Camp that will take place in June 2015 
 
